CAI

NASDAQ 已收盘

Caris Life Sciences

18.54 USD
▼-0.96-4.92%
盘后 18.54 0.00%
2026-11-19
市值
$5.14B
市盈率
53.77
EPS
0.33
股息率
—
52 周区间
14.19 – 36.50
成交量
3.63M
Beta
—
目标价
34.23
52W 低 14.1952W 高 36.50
价格走势

公司简介

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company’s molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecula...